KBC Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $82.9M | Sell |
|
|||||
2025
Q1 | $88.7M | Buy |
|
|||||
2024
Q4 | $87.6M | Buy |
|
|||||
2024
Q3 | $89.9M | Buy |
|
|||||
2024
Q2 | $69M | Sell |
|
|||||
2024
Q1 | $279M | Buy |
|
|||||
2023
Q4 | $126M | Buy |
|
|||||
2023
Q3 | $104M | Buy |
|
|||||
2023
Q2 | $109M | Sell |
|
|||||
2023
Q1 | $152M | Sell |
|
|||||
2022
Q4 | $200M | Sell |
|
|||||
2022
Q3 | $180M | Buy |
|
|||||
2022
Q2 | $213M | Buy |
|
|||||
2022
Q1 | $176M | Buy |
|
|||||
2021
Q4 | $165M | Buy |
|
|||||
2021
Q3 | $87.5M | Sell |
|
|||||
2021
Q2 | $125M | Buy |
|
|||||
2021
Q1 | $97.1M | Buy |
|
|||||
2020
Q4 | $443M | Sell |
|
|||||
2020
Q3 | $92.8M | Sell |
|
|||||
2020
Q2 | $193M | Buy |
|
|||||
2020
Q1 | $98.9M | Buy |
|
|||||
2019
Q4 | $98.8M | Sell |
|
|||||
2019
Q3 | $142M | Buy |
|
|||||
2019
Q2 | $159M | Sell |
|
|||||
2019
Q1 | $169M | Buy |
|
|||||
2018
Q4 | $170M | Sell |
|
|||||
2018
Q3 | $173M | Buy |
|
|||||
2018
Q2 | $125M | Sell |
|
|||||
2018
Q1 | $130M | Buy |
|
|||||
2017
Q4 | $112M | Sell |
|
|||||
2017
Q3 | $118M | Buy |
|
|||||
2017
Q2 | $109M | Sell |
|
|||||
2017
Q1 | $117M | Sell |
|
|||||
2016
Q4 | $161M | Buy |
|
|||||
2016
Q3 | $151M | Buy |
|
|||||
2016
Q2 | $95.8M | Buy |
|
|||||
2016
Q1 | $75.8M | Buy |
|
|||||
2015
Q4 | $68.1M | Buy |
|
|||||
2015
Q3 | $58.9M | Sell |
|
|||||
2015
Q2 | $95.6M | Sell |
|
|||||
2015
Q1 | $103M | Sell |
|
|||||
2014
Q4 | $104M | Buy |
|
|||||
2014
Q3 | $11.7M | Sell |
|
|||||
2014
Q2 | $95.9M | Buy |
|
|||||
2014
Q1 | $85.6M | Sell |
|
|||||
2013
Q4 | $95.2M | Buy |
|
|||||
2013
Q3 | $87.9M | Buy |
|
|||||
2013
Q2 | $84.7M | Buy |
|